Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6463068rdf:typepubmed:Citationlld:pubmed
pubmed-article:6463068lifeskim:mentionsumls-concept:C0006852lld:lifeskim
pubmed-article:6463068lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:6463068lifeskim:mentionsumls-concept:C0013547lld:lifeskim
pubmed-article:6463068lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:6463068lifeskim:mentionsumls-concept:C0069765lld:lifeskim
pubmed-article:6463068lifeskim:mentionsumls-concept:C0205171lld:lifeskim
pubmed-article:6463068pubmed:issue10lld:pubmed
pubmed-article:6463068pubmed:dateCreated1984-9-20lld:pubmed
pubmed-article:6463068pubmed:abstractTextFifty-one women with vaginal candidiasis were included in an open randomized study to compare the efficacy and local tolerance of a single-dose treatment with 600 mg oxiconazole (one vaginal tablet) with that of a 3-day treatment with econazole (one 150 mg ovule daily). Twenty-five patients were treated with oxiconazole and the remaining 26 received econazole. Patients were followed-up 1 week and 4 to 5 weeks after the initial examination and details were recorded of the results of yeast culture, the clinical signs and symptoms present and any signs of intolerance. A cure rate of 92% was achieved in both treatment groups and only 1 patient (econazole group) of the 4 treatment failures (2 in each group) did not respond to a subsequent second course with the same treatment schedule. Vaginal burning was the only reported local side-effect in 5 patients of the oxiconazole group and in 6 of the econazole group.lld:pubmed
pubmed-article:6463068pubmed:languageenglld:pubmed
pubmed-article:6463068pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6463068pubmed:citationSubsetIMlld:pubmed
pubmed-article:6463068pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6463068pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6463068pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6463068pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6463068pubmed:statusMEDLINElld:pubmed
pubmed-article:6463068pubmed:issn0308-051Xlld:pubmed
pubmed-article:6463068pubmed:authorpubmed-author:GouveiaD CDClld:pubmed
pubmed-article:6463068pubmed:authorpubmed-author:Jones da...lld:pubmed
pubmed-article:6463068pubmed:issnTypePrintlld:pubmed
pubmed-article:6463068pubmed:volume3lld:pubmed
pubmed-article:6463068pubmed:ownerNLMlld:pubmed
pubmed-article:6463068pubmed:authorsCompleteYlld:pubmed
pubmed-article:6463068pubmed:pagination682-5lld:pubmed
pubmed-article:6463068pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6463068pubmed:meshHeadingpubmed-meshheading:6463068-...lld:pubmed
pubmed-article:6463068pubmed:meshHeadingpubmed-meshheading:6463068-...lld:pubmed
pubmed-article:6463068pubmed:meshHeadingpubmed-meshheading:6463068-...lld:pubmed
pubmed-article:6463068pubmed:meshHeadingpubmed-meshheading:6463068-...lld:pubmed
pubmed-article:6463068pubmed:meshHeadingpubmed-meshheading:6463068-...lld:pubmed
pubmed-article:6463068pubmed:meshHeadingpubmed-meshheading:6463068-...lld:pubmed
pubmed-article:6463068pubmed:meshHeadingpubmed-meshheading:6463068-...lld:pubmed
pubmed-article:6463068pubmed:meshHeadingpubmed-meshheading:6463068-...lld:pubmed
pubmed-article:6463068pubmed:meshHeadingpubmed-meshheading:6463068-...lld:pubmed
pubmed-article:6463068pubmed:meshHeadingpubmed-meshheading:6463068-...lld:pubmed
pubmed-article:6463068pubmed:year1984lld:pubmed
pubmed-article:6463068pubmed:articleTitleOxiconazole in the treatment of vaginal candidiasis: single dose versus 3-day treatment with econazole.lld:pubmed
pubmed-article:6463068pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6463068pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:6463068pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6463068pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6463068lld:pubmed